CS
ALPN

Credit Suisse’s Alpine Immune Sciences Inc ALPN Stock Holding History

Credit Suisse’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.28M Buy
32,211
+5,467
+20% +$161K ﹤0.01% 2119
2023
Q4 		$510K Buy
26,744
+11,535
+76% +$160K ﹤0.01% 2715
2023
Q3 		$174K Buy
+15,209
New +$187K ﹤0.01% 3050
2023
Q1 		– Sell
-1
Closed -$7 – 3829
2022
Q4 		$7 Sell
1
-84
-99% -$537 ﹤0.01% 3789
2022
Q3 		$1K Buy
85
+70
+467% +$577 ﹤0.01% 3968
2022
Q2 		$0 Buy
+15
New +$129 ﹤0.01% 4434
2015
Q4 		– Sell
-3,949
Closed -$205K – 4392
2015
Q3 		$205K Buy
+3,949
New +$259K ﹤0.01% 3916

Other funds holding ALPN

DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Credit Suisse's ALPN Position: Q1 2024 in Review

Credit Suisse increased its Alpine Immune Sciences Inc (ALPN) stake by 20% in Q1 2024, buying an estimated $161K and bringing the position to 32,211 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2119.

Credit Suisse first reported a position in ALPN in Q3 2015 and has held it in 7 quarters since. 180 funds tracked by Wall St. Rank hold ALPN as of Q1 2024.

  • Credit Suisse held 32,211 shares of Alpine Immune Sciences Inc worth $1.28M as of Q1 2024.
  • Credit Suisse bought 5,467 Alpine Immune Sciences Inc shares in Q1 2024, an estimated $161K.
  • Alpine Immune Sciences Inc made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2119 holding.
  • Credit Suisse first reported a position in Alpine Immune Sciences Inc in Q3 2015 and has held it in 7 quarters since.
  • 180 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.